Latigo Biotherapeutics, Inc. (NASDAQ:LTGO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Timothy P. Walbert Other companies: Kardigan, Inc. (Board of Directors · Since at least Jun 17, 2026); Odyssey Therapeutics, Inc. (Director · Since at least May 7, 2026); BioMarin Pharmaceutical Inc. (Director · Since at least Feb 24, 2025); Sagimet Biosciences Inc. - Series A (Director · Since at least Apr 1, 2024); Mirum Pharmaceuticals, Inc. (Director · Since at least Apr 5, 2023); Century Therapeutics, Inc. (Director · Since at least Oct 1, 2022); Aurinia Pharmaceuticals Inc (Director · Jan 1, 2021 – May 18, 2022 · Past); Assertio Holdings, Inc. (Director · May 20, 2020 – May 20, 2020 · Past); Exicure, Inc. (Director · Jul 22, 2019 – Jun 2, 2021 · Past); Sucampo Pharmaceuticals Inc (Director · Oct 12, 2015 – Feb 13, 2018 · Past); Egalet Corporation (Director · Mar 10, 2014 – May 20, 2020 · Past); Horizon Pharma PLC (Chairman, President and CEO, Director · Jul 28, 2011 – Mar 23, 2019 · Past); Raptor Pharmaceutical Corp (Director · Apr 11, 2011 – Mar 13, 2014 · Past); Idm Pharma Inc (President and CEO, Director · May 25, 2007 – Apr 3, 2008 · Past) | Chair, Board of Directors · Since at least Aug 6, 2026 |
| Beth C Seidenberg Other companies: Kyverna Therapeutics, Inc. (Director · Since at least Feb 7, 2024); Sagimet Biosciences Inc. - Series A (Director · Since at least Jul 13, 2023); Vera Therapeutics, Inc. (Director · Since at least May 13, 2021); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Progyny, Inc. (Director · Oct 24, 2019 – May 23, 2024 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Jun 22, 2018 · Past); Atara Biotherapeutics, Inc. (Director · Oct 15, 2014 – May 31, 2023 · Past); Epizyme Inc (Director · May 30, 2013 – Jun 30, 2019 · Past); Tesaro Inc (Director · Jun 27, 2012 – Jan 22, 2019 · Past) | Director · Since at least Aug 6, 2026 |
| Jim Tananbaum Other companies: Alumis Inc. (Director · Since at least Jun 27, 2024); Quantum-Si Incorporated (Director · Jun 10, 2021 – Jun 10, 2021 · Past); Pardes Biosciences Inc (President and CEO, Director · Feb 16, 2021 – Aug 31, 2023 · Past); Kinnate Biopharma Inc (Director · Dec 2, 2020 – Apr 3, 2024 · Past); Disc Medicine, Inc. (Director · Aug 11, 2020 – Oct 4, 2021 · Past) | Director · Since at least Aug 6, 2026 |
| Sara Bonstein Other companies: Xilio Therapeutics, Inc. (Chair of the Board · Since at least Oct 21, 2021); Scpharmaceuticals Inc (Director · Since at least Jul 8, 2020); Insmed Incorporated (Chief Financial Officer · Since at least Jan 31, 2020); Advaxis Inc (Chief Financial Officer · Mar 31, 2014 – Mar 29, 2018 · Past) | Independent Director · Since at least Aug 6, 2026 |
| Todd Smith Other companies: Assertio Holdings, Inc. (Director, Pres & CEO, Director · May 20, 2020 – May 20, 2020 · Past); Egalet Corporation (President and CEO, Director · Oct 23, 2019 – May 20, 2020 · Past); IVERIC bio Inc (SVP & CCO · Oct 3, 2014 – Jan 2, 2015 · Past); Horizon Pharma PLC (EVP, Chief Commercial Officer · Jul 28, 2011 – Sep 19, 2014 · Past) | president and chief executive officer, Director · Since at least Aug 6, 2026 |
| Beth Seidenberg Other companies: Sagimet Biosciences Inc. - Series A (Lead Independent Director · Since at least Nov 4, 2026); Vera Therapeutics, Inc. (Founding Managing Director, Westlake Village BioPartners · Since at least Nov 4, 2026); Kyverna Therapeutics, Inc. (Independent Director · Since at least May 29, 2026) | Founding Managing Director, Westlake BioPartners · Since at least Aug 10, 2026 |
| Neha Krishnamohan Other companies: Artiva Biotherapeutics, Inc. (Chief Financial Officer · Since at least Jul 18, 2024); Arcutis Biotherapeutics, Inc. (Director · Since at least Sep 2, 2022); Kinnate Biopharma Inc (CHIEF FINANCIAL OFFICER · Jun 7, 2021 – Apr 3, 2024 · Past) | Chief Financial Officer and Chief Business Officer · Since at least Aug 6, 2026 |
| Nima Farzan Other companies: Keros Therapeutics, Inc. (Director · Since at least Apr 7, 2020); Kinnate Biopharma Inc (CHIEF EXECUTIVE OFFICER, Director · Dec 2, 2020 – Apr 3, 2024 · Past) | President and CEO, Director · Since at least Aug 6, 2026 |
| Ada Kumar | Vice President, Medical Affairs · Since at least Nov 4, 2026 |
| Anil Chhettry | Vice President, Chemistry, Manufacturing and Controls · Since at least Nov 4, 2026 |
| Becky Baggett | Vice President, Clinical Operations · Since at least Nov 4, 2026 |
| Ben Vaughn | Vice President, Biostatistics · Since at least Nov 4, 2026 |
| Bryan Moyer | Senior Vice President, Discovery · Since at least Nov 4, 2026 |
| Caroline Dougherty | Vice President, Corporate Development · Since at least Nov 4, 2026 |
| Cynthia Voong | Vice President, Clinical Operations · Since at least Nov 4, 2026 |
| Holly Carlisle | Vice President, Translational Science · Since at least Nov 4, 2026 |
| Julia Chapman | Senior Vice President, Operations · Since at least Nov 4, 2026 |
| Kevin Raidy | Senior Managing Director, Blue Owl Capital · Since at least Aug 6, 2026 |
| Mike Kaufman | Vice President, Chemistry · Since at least Nov 4, 2026 |
| Naomi Lowy | Senior Vice President, Global Regulatory Affairs · Since at least Nov 4, 2026 |
| Neil Singla | Chief Medical Officer · Since at least Aug 6, 2026 |
| Polina German | Senior Vice President, Clinical Pharmacology and Translational · Since at least Nov 4, 2026 |
| Sabrina Nieder | Vice President, Corporate Controller · Since at least Nov 4, 2026 |
| Tim Clark | Vice President, Government Affairs · Since at least Nov 4, 2026 |